close Video

NEW You can now listen to Fox News articles!

The U.S. Food and Drug Administration (FDA) announced it is initiating the removal of "black box" warning labels from hormone replacement therapy (HRT) products used to ease menopause symptoms , a move Commissioner Dr. Marty Makary said is backed by decades of research on the therapy’s benefits and clinical trials that do not support earlier fears linking it to higher breast cancer mortality.

Health and Human Services Secretary (HHS) Robert F. Kennedy Jr. said at a press conference alongside Makary on Monday that the so-called "black box" labels, the strongest warnings for prescription drugs the agency can require, were designed to "frighten women and to silence doctors."

"It warned of diseases and dangers that the data

See Full Page